Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-11-28FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for desipramine hydrochloride from Actavis Pharma, Inc., signaling an additional approval under an a…
-
FDA approval · 2007-11-28FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for desipramine hydrochloride, authorizing a change to an already approved product filed by Actavis …
-
FDA approval · 2007-11-28FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for desipramine hydrochloride by Actavis Pharma, Inc., approving the generic drug submission.
-
FDA approval · 2007-11-26FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)
FDA granted a supplemental approval to Aurolife Pharma LLC for Mirtazapine (generic antidepressant) under an ANDA.
-
CLINICAL_TRIALS research · 2007-11-22Clinical Trial Update: Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid Hormones [NA]
A clinical trial update reports that biochemical brain changes accompany the antidepressant effects of thyroid hormones in major depressive …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-11-14Clinical Trial Update: A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder [Phase 2]
Phase 2 efficacy trial of PRX-00023 in Major Depressive Disorder has been completed. The study was sponsored by Epix Pharmaceuticals.
-
CLINICAL_TRIALS research · 2007-11-14Clinical Trial Update: Comparison of Thiopental and Propofol as Anaesteticum During ECT [NA]
A clinical trial comparing thiopental versus propofol as anesthesia during electroconvulsive therapy for depression; the current status is u…
-
FDA approval · 2007-11-13FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for trazodone hydrochloride by Sun Pharmaceutical Industries, approving changes to its generic produ…
-
CLINICAL_TRIALS trial_result · 2007-11-08Clinical Trial Update: Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression (rTMS) [Phase 3]
A Phase 3 study of repetitive transcranial magnetic stimulation for treatment-refractory depression was terminated.
-
FDA approval · 2007-11-07FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' supplemental application for mirtazapine (generic) under an ANDA, authorizing the continued …
-
FDA approval · 2007-11-07FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic combination product perphenazine and amitriptyline hydrochloride by Mylan Pharmaceut…
-
FDA approval · 2007-11-06FDA Approved: MIRTAZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Mirtazapine submitted by Mylan Pharmaceuticals Inc., authorizing the generic version of the …
-
FDA approval · 2007-11-06FDA Approved: MIRTAZAPINE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application submitted by Apotex Corp. for mirtazapine.
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: A Randomized Controlled Clinical Trial With Orphans and Widows Who Experienced the Rwandan Genocide [Phase 1]
Phase 1 randomized controlled trial conducted in Rwanda examining treatments for post-traumatic stress disorder, depression, and prolonged g…
-
CLINICAL_TRIALS trial_result · 2007-11-05Clinical Trial Update: Transcranial Magnetic Stimulation (rTMS) Accelerates the Response to Escitalopram in Major Depression [NA]
A clinical trial found that transcranial magnetic stimulation (rTMS) accelerates the response to escitalopram in patients with major depress…
-
FDA approval · 2007-11-01FDA Approved: CITALOPRAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for the generic antidepressant Citalopram from Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2007-10-31Clinical Trial Update: Effects of Ghrelin on the Sleep-EEG and Nocturnal Secretion of Hormones [NA]
A completed clinical trial investigating the effects of ghrelin on sleep-EEG patterns and nocturnal hormone secretion in healthy individuals…
-
FDA approval · 2007-10-30FDA Approved: MIRTAZAPINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for mirtazapine from Aurobindo Pharma Limited, enabling a regulatory update for this generic ant…
-
FDA approval · 2007-10-29FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for the generic antidepressant mirtazapine from Sun Pharmaceutical Industries, Inc., under ANDA 0765…
-
FDA approval · 2007-10-29FDA Approved: NEFAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for nefazodone hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2007-10-25FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Citalopram hydrobromide from Aurobindo Pharma Limited, granting generic approval for their Cital…
-
FDA approval · 2007-10-25FDA Approved: CITALOPRAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for citalopram from Hikma Pharmaceuticals USA Inc., granting approval for its generic antidepressant…
-
FDA approval · 2007-10-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride, a generic sertraline product, under the ANDA.
-
CLINICAL_TRIALS trial_result · 2007-10-19Clinical Trial Update: Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining Remission [Phase 4]
A Phase 4 trial evaluating venlafaxine (Effexor) for achieving response and maintaining remission in depression has completed. The sponsor i…
-
CLINICAL_TRIALS trial_result · 2007-10-19Clinical Trial Update: Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients [Phase 4]
Phase 4 trial update indicating the venlafaxine extended-release study in anxious and depressed patients has been completed.